Fletcher/CSI to Take Part in the First Annual Pharma CI Europe Conference and Exhibition

Share Article

Fletcher/CSI to take part in the First Annual Pharma CI Europe Conference and Exhibition.

News Image
The US event is known for impactful networking for everyone who attends because it truly brings together all the intelligence industry's experts under one roof. I am personally looking forward to attending the first European event.

Fletcher/CSI, LLC, experts in competitive intelligence and primary research, announced today that they will be presenting at Pharma CI Europe Conference.

By popular demand, the world's largest pharmaceutical competitive intelligence conference is holding its first European event in Zurich on February 21-22, 2012. Fletcher/CSI Healthcare Strategie s has been the main sponsor of the Pharma CI USA Conference for 10 years, and now we are excited to be sponsoring the European conference as well.

On Tuesday, February 21, Erik Glitman, CEO of Fletcher/CSI, will be presenting the session “Effective CI Organizations.” Glitman will present the results of our survey that details the characteristics of a successful and engaged CI unit. The session will present the latest data on how CI professionals work with their internal clients to stay relevant and proactive; how CI units use external resources to leverage internal capabilities and increase effectiveness; And finally, how to structure and align your CI unit with success.

Erik Glitman, Fletcher/CSI’s CEO, stated that “Fletcher/CSI Healthcare Strategies is a trusted advisor to life science clients and a top choice provider of high-impact, competitive intelligence-based consulting services. Since 1986, we have helped our clients outmaneuver and outperform their competitors and since opening our European office last year, we have been bringing this expertise to the European market. Being part of Pharma CI Europe is an important part of our expansion into the European community.”

Based on a foundation of therapeutic category expertise and functional life science business experience, Fletcher/CSI Healthcare Strategies utilizes competitor and market intelligence collection, analysis, and reporting to provide critical insight and recommendations to their clients. Understanding the marketplace and each client’s challenges gives Fletcher/CSI an advantage in helping clients identify, assess, and target critical industry movements and competitor tactical and strategic direction.

As the founder, lead sponsor, and co-coordinator of the American event for over ten years, Fletcher/CSI has worked with the Pharma CI Conference organizers to bring together a wealth of people, resources, and critical contemporary perspectives designed to address the industry’s current competitive challenges. Cinda Steele, Senior VP Fletcher/CSI Healthcare Strategies, said "The US event is known for impactful networking for everyone who attends because it truly brings together all the intelligence industry's experts under one roof. I am personally looking forward to attending the first European event. Attending this event gives Fletcher/CSI the opportunity to participate and help shape the industry."

To learn more about the event, see the complete agenda, and to register, please visit Pharma CI 2012 Europe.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lynda Engler